Drooid Logo
Back to today’s briefing

Story perspectives

Sen. Scott's CLEAR LABELS Act Boosts Drug Transparency

1/30/2026

30 2

1 of 1

Story summary
  • Sen. Rick Scott (R-Fla.) introduced the CLEAR LABELS Act requiring prescription drug labels to disclose original generic drug manufacturers.
  • The measure aims to boost transparency, address safety concerns about medicines from China and India, and support American jobs.
  • The bill aligns with a Senate labeling hearing.
  • It follows a bipartisan report directed by Sen. Kirsten Gillibrand (D-N.Y.) urging the prioritization of American-made active pharmaceutical ingredients.